This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Sagent Pharmaceuticals Co (SGNT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 42.33M 27.69M 52.20M 34.38M
Receivables 26.68M 33.05M 31.41M 19.93M
Inventories 46.48M 47.11M 41.49M 30.57M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 235.79M 147.27M 200.85M 90.39M
Property, Plant & Equipment, Gross 60.39M 1.87M 1.76M 1.57M
Accumulated Depreciation & Depletion 2.71M 1.09M 872.00K 788.00K
Property, Plant & Equipment, Net 57.68M 780.00K 884.00K 785.00K
Intangibles 8.33M 4.28M 5.43M 2.61M
Other Non-Current Assets 2.37M 19.99M 23.35M 24.80M
Total Non-Current Assets 74.42M 25.05M 29.66M 28.20M
Liabilities & Shareholder Equity
Total Assets 310.21M 172.32M 230.51M 118.59M
Accounts Payable 28.07M 28.84M 39.71M 26.94M
Short Term Debt 10.33M 0.00 8.18M 0.00
Other Current Liabilities 4.28M 0.00 0.00 1.43M
Total Current Liabilities 63.52M 40.45M 84.14M 57.62M
Long Term Debt 0.00 0.00 4.09M 0.00
Deferred Income Taxes 0.00 0.00 0.00 6.00K
Other Non-Current Liabilities 10.66M 6.00K 606.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 10.66M 6.00K 4.70M 6.00K
Total Liabilities 74.18M 40.46M 88.84M 57.62M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 236.03M 131.86M 141.67M 60.96M
Common Par 318.00K 281.00K 279.00K 206.00K
Additional Paid In Capital 349.28M 272.72M 266.06M 159.89M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -114.06M -143.65M -126.83M -100.41M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 487.00K 2.50M 2.16M 1.28M
Total Capitalization 236.03M 131.86M 145.76M 60.96M
Total Equity 236.03M 131.86M 141.67M 60.96M
Total Liabilities & Stock Equity 310.21M 172.32M 230.51M 118.59M
Total Common Shares Outstanding 31.79M 28.12M 27.90M 26.85M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 29.21M 27.98M 20.10M 15.28M
Diluted Weighted Shares Outstanding 29.94M 27.98M 20.10M 15.28M
Number of Employees 269 98 99 85
Number of Part-Time Employees 0 0 0 0

SGNT Sagent Pharmaceuticals Co

Analysts Ratings for SGNT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

SGNT Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs